BACKGROUND: In early 2005 the UK Committee on Safety of Medicines (CSM) announced gradual withdrawal of the analgesic co-proxamol because of its adverse benefit/safety ratio, especially its use for intentional and accidental fatal poisoning. Prescriptions of co-proxamol were reduced in the 3-year withdrawal phase (2005 to 2007) following the CSM announcement. AIMS: To assess the impact of the CSM announcement in January 2005 to withdraw co-proxamol on nonfatal self-poisoning with co-proxamol ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Impact of withdrawal of the analgesic Co-proxamol on nonfatal self-poisoning in the UK.
If you are the owner of this record, you can report an update to it here: Report update to this record